FTO and nonpapillary renal cell carcinoma: Although our findings offer mechanistic insights into the functional role of FTO in ccRCC and provide proof-of-concept data supporting the potential of FTO inhibitors in combination therapy for ccRCC treatment, there are several limitations to this study.